As of 3:51pm ET
| +0.90 / +1.25%|
The 4 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 74.50, with a high estimate of 89.00 and a low estimate of 69.00. The median estimate represents a +2.34% increase from the last price of 72.80.
The current consensus among 6 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.